APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753U956. A total of 5 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,898,460 | -25.5% | 286,500 | +78.4% | 0.00% | -20.0% |
Q2 2023 | $14,630,660 | +48.8% | 160,600 | +7.7% | 0.01% | +25.0% |
Q1 2023 | $9,834,636 | +214.4% | 149,100 | +146.4% | 0.00% | +300.0% |
Q4 2022 | $3,128,455 | -62.1% | 60,500 | -49.9% | 0.00% | -75.0% |
Q3 2022 | $8,244,000 | +40.2% | 120,700 | -7.2% | 0.00% | +100.0% |
Q2 2022 | $5,879,000 | – | 130,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GROUP ONE TRADING, L.P. | 123,300 | $11,232,630 | 0.04% |
SIMPLEX TRADING, LLC | 200,500 | $18,265 | 0.02% |
Worth Venture Partners, LLC | 21,800 | $13,898 | 0.01% |
JANE STREET GROUP, LLC | 160,600 | $14,630,660 | 0.01% |
Twin Tree Management, LP | 15,200 | $1,384,720 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |